Found: 45
Select item for more details and to access through your institution.
MODUL—a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 6, p. 1197, doi. 10.1007/s00432-018-2632-6
- By:
- Publication type:
- Article
New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal Cancer.
- Published in:
- Current Oncology Reports, 2016, v. 18, n. 3, p. 1, doi. 10.1007/s11912-016-0504-2
- By:
- Publication type:
- Article
Rectal Hodgkin disease and the acquired immunodeficiency syndrome.
- Published in:
- 1987
- By:
- Publication type:
- Case Study
Sequential karyotype study on Ph-positive chronic myelocytic leukemia. Significance of additional chromosomal abnormalities during disease evolution.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's disease.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Preleukemic changes in cases of nonlymphocytic leukemia secondary to cytotoxic therapy. Analysis of 105 cases.
- Published in:
- 1986
- By:
- Publication type:
- journal article
Erythrocyte mean corpuscular volume during cytotoxic therapy and the risk of secondary leukemia.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients.
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 69, n. 1, p. 58, doi. 10.1111/j.1365-2125.2009.03556.x
- By:
- Publication type:
- Article
Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes--An ESDO Report.
- Published in:
- Cancers, 2017, v. 9, n. 6, p. 59, doi. 10.3390/cancers9060059
- By:
- Publication type:
- Article
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma.
- Published in:
- Cancer (0008543X), 1997, v. 79, n. 6, p. 1100, doi. 10.1002/(SICI)1097-0142(19970315)79:6<1100::AID-CNCR7>3.0.CO;2-J
- By:
- Publication type:
- Article
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
- Published in:
- 1997
- By:
- Publication type:
- journal article
Acute Leukemia after Treatment for Ovarian Cancer.
- Published in:
- Oncology, 1986, v. 43, n. 3, p. 165, doi. 10.1159/000226357
- By:
- Publication type:
- Article
Acute Leukemia Secondary to Lung Cancer.
- Published in:
- Oncology, 1985, v. 42, n. 2, p. 107, doi. 10.1159/000226011
- By:
- Publication type:
- Article
Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 3, p. 153, doi. 10.1177/1758834015572343
- By:
- Publication type:
- Article
Therapeutic strategy in unresectable metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2012, v. 4, n. 2, p. 75, doi. 10.1177/1758834011431592
- By:
- Publication type:
- Article
BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Colorectal cancer: integrating oxaliplatin.
- Published in:
- 2003
- By:
- Publication type:
- journal article
FOLFOX in Patients Aged Between 76 and 80 Years With Metastatic Colorectal Cancer.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 12, p. 2666, doi. 10.1002/cncr.23091
- By:
- Publication type:
- Article
Consensus report of the International Society of Gastrointestinal Oncology on therapeutic progress in advanced pancreatic cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 4, p. 676, doi. 10.1002/cncr.22036
- By:
- Publication type:
- Article
Correlation between progression free survival and response rate in patients with metastatic colorectal carcinoma.
- Published in:
- Cancer (0008543X), 2001, v. 91, n. 11, p. 2033, doi. 10.1002/1097-0142(20010601)91:11<2033::AID-CNCR1229>3.0.CO;2-J
- By:
- Publication type:
- Article
Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 Patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Understanding the Prognostic Value of Primary Tumor Location and KRAS in Metastatic Colorectal Cancer: A Post Hoc Analysis of the OPTIMOX3 DREAM Phase III Study.
- Published in:
- Clinical Colorectal Cancer, 2020, v. 19, n. 3, p. 200, doi. 10.1016/j.clcc.2020.02.012
- By:
- Publication type:
- Article
Safety analysis of FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studies.
- Published in:
- 2012
- By:
- Publication type:
- journal article
The evolution of adjuvant therapy in the treatment of early-stage colon cancer.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Targeted Therapies as Adjuvant Treatment for Early-Stage Colorectal Cancer: First Impressions and Clinical Questions.
- Published in:
- Clinical Colorectal Cancer, 2010, v. 9, n. 5, p. 269, doi. 10.3816/CCC.2010.n.039
- By:
- Publication type:
- Article
Comparison of the Levogyre and Dextro-Levogyre Forms of Leucovorin in a Phase III Trial of Bimonthly LV5FU2 Versus Monthly 5-Fluorouracil and High-Dose Leucovorin for Patients With Stage II and III Colon Cancer (GERCOR C96.1).
- Published in:
- Clinical Colorectal Cancer, 2010, v. 9, n. 2, p. E5, doi. 10.3816/CCC.2010.n.027
- By:
- Publication type:
- Article
Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first-line therapy for metastatic colorectal cancer: GERCOR VELVET phase II study.
- Published in:
- International Journal of Oncology, 2019, v. 54, n. 4, p. 1433, doi. 10.3892/ijo.2019.4709
- By:
- Publication type:
- Article
Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial.
- Published in:
- PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0157067
- By:
- Publication type:
- Article
Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer: The results of the GERCOR OPTIMOX 1 study.
- Published in:
- Health & Quality of Life Outcomes, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1477-7525-12-69
- By:
- Publication type:
- Article
Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.
- Published in:
- Acta Oncologica, 2016, v. 55, n. 9/10, p. 1168, doi. 10.1080/0284186X.2016.1191670
- By:
- Publication type:
- Article
Investigating the Potential of Bevacizumab in Other Indications: Metastatic Renal Cell, Non-Small Cell Lung, Pancreatic and Breast Cancer.
- Published in:
- Oncology, 2005, v. 69, p. 46, doi. 10.1159/000088483
- By:
- Publication type:
- Article
The Oncosurgery Approach to Managing Liver Metastases from Colorectal Cancer: A Multidisciplinary International Consensus.
- Published in:
- Oncologist, 2012, v. 17, n. 10, p. 1225, doi. 10.1634/theoncologist.2012-0121
- By:
- Publication type:
- Article
The ARCAD Clinical Trials Program: An Update and Invitation.
- Published in:
- Oncologist, 2012, v. 17, n. 2, p. 188, doi. 10.1634/theoncologist.2011-0332
- By:
- Publication type:
- Article
Simplified Prognostic Model in Patients with Oxaliplatin-Based or Irinotecan-Based First-Line Chemotherapy for Metastatic Colorectal Cancer: A GERCOR Study.
- Published in:
- Oncologist, 2011, v. 16, n. 9, p. 1228, doi. 10.1634/theoncologist.2011-0039
- By:
- Publication type:
- Article
STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1503-7
- By:
- Publication type:
- Article
STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 496, doi. 10.1186/s12885-015-1503-7
- By:
- Publication type:
- Article
STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database.
- Published in:
- 2021
- By:
- Publication type:
- journal article
BRAF V600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD Database.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Threshold Change in CEA as a Predictor of Non-Progression to First-Line Systemic Therapy in Metastatic Colorectal Cancer Patients With Elevated CEA.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Adverse event load, onset, and maximum grade: A novel method of reporting adverse events in cancer clinical trials.
- Published in:
- Clinical Trials, 2021, v. 18, n. 1, p. 51, doi. 10.1177/1740774520959313
- By:
- Publication type:
- Article
A NEW CASE OF DE NOVO AML WITH 9q INTERSTITIAL DELETION AS THE SOLE CHROMOSOMAL ABNORMALITY.
- Published in:
- British Journal of Haematology, 1987, v. 67, n. 4, p. 494, doi. 10.1111/j.1365-2141.1987.tb06177.x
- By:
- Publication type:
- Article